Fed Sparks Profit T...
Health Care: Drugs
NeurogesX Inc. (NGSX: OTC)
$0.01 0.00 | 10.00%
05/24/13 - 03:39 PM ET
TheStreet Ratings Grade for NGSX
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0.00 | 0.00 | 0.00 | 1.00 |
Portfolios with NGSX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 29
- UserGFNN Stockdiagnostics 22
- UserSaveyn walter
- UserGFNN Stockdiagnostics 12
- Contributor5 Health Care Stocks With U...
- Contributor10 Biotech Stocks Expected ...
- UserSUPRATRADE STRONG BUY-25090...
- ContributorCharts of the Week - 7-22-2009
- UserBENITRANS IH
- Userirvgruve Portfolio 1
Latest NGSX Headlines from TheStreet
- NeurogesX To Present At Rodman & Renshaw 14th Annual Healthcare Conference 09.05.12 | 08:09 am
- NeurogesX' NGX-1998 Well-Tolerated Treatment Demonstrated Clear Dose-Response In Patients 08.30.12 | 11:08 am
- NeurogesX To Present At Wedbush PacGrow 2012 Life Sciences Management Access Conference 08.09.12 | 08:08 am
- NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.06.12 | 05:08 am
- Insiders Trading TXI, P, NGSX, CNK 06.21.11 | 09:06 am
- 5 Health Care Stocks With Upside 03.21.11 | 11:03 am
- 10 Biotech Stocks Expected to at Least Double 10.19.10 | 06:10 am
- Stock Offerings: Kodiak Oil & Gas 08.13.10 | 09:08 am
- NeurogesX Inc. Q1 2010 Earnings Call Transcript 05.11.10 | 10:05 pm
- Earnings Roundup: Palm, Cintas 03.18.10 | 06:03 pm
Press Releases for NGSX
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In NeurogesX, Inc. Of Class Action Lawsuit - PR Newswire 04.23.12 | 05:04 pm
- Qutenza(R) (capsaicin) 8% Patch For Treatment Of Post-Shingles Pain Now Available - PR Newswire 04.05.10 | 08:04 am
- NeurogesX To Present At BioCentury Future Leaders In The Biotech Industry Conference - PR Newswire 04.01.10 | 01:04 pm
Partner Headlines for NGSX
- NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance - Benzinga 04.20.12 | 04:04 pm
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Market Gives Up Gains Ahead of House Vote - Benzinga 07.28.11 | 04:07 pm
- Morning Market Movers - Benzinga 06.16.11 | 09:06 am
- Biotech CROs Take Center Stage in Recent Deals - Seeking Alpha 05.02.10 | 05:05 am
- UPDATE 1-NeurogesX says shingles-pain patch available, shares up - Reuters 04.05.10 | 02:04 pm
- Volume Talks Wednesday: A Bullish Biotech Breakout Option Play - SeekingAlpha.com 03.25.10 | 12:03 am
